Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Type-2 diabetes

    Tag: type 2 diabetes

    You Searched For "Type-2 diabetes"
    Dapagliflozin is new treatment for heart failure, finds NEJM study

    Dapagliflozin is new treatment for heart failure, finds NEJM study

    Dr. Kamal Kant Kohli Kohli20 Sept 2019 8:28 PM IST
    Heart failure occurs when the heart is no longer able to efficiently pump blood in the body as it should. Diuretics and Ace inhibitors have been the...
    Long term use of ACE inhibitors not only lowers BP, but reduces diabetes risk also

    Long term use of ACE inhibitors not only lowers BP, but reduces diabetes risk also

    Hina Zahid21 Sept 2019 8:55 AM IST
    Angiotensin-converting enzyme (ACE) inhibitors are high blood pressure drugs that dilate blood vessels to increase blood flow and lower high blood...
    FDA approves first ever oral Semaglutide for blood sugar control in type 2 diabetes

    FDA approves first ever oral Semaglutide for blood sugar control in type 2 diabetes

    Dr. Kamal Kant Kohli Kohli20 Sept 2019 8:20 PM IST
    Food and Drug Administration has approved first GLP-1 oral drug Semaglutide for blood sugar control in type 2 diabetes.The U.S. Food and Drug...
    Vildagliptin, Metformin combo shows long term blood sugar control in newly diagnosed diabetics

    Vildagliptin, Metformin combo shows long term blood sugar control in newly diagnosed diabetics

    Deepanjana Sarkar23 Sept 2019 8:30 PM IST
    Barcelona, Spain: Results from a recent Phase IV clinical study--VERIFY-- has shown better blood sugar control in patients who are on Early...
    New research targets metformin as breast cancer prescription: International Journal of Cancer 

    New research targets metformin as breast cancer prescription: International Journal of Cancer 

    Hina Zahid24 Sept 2019 7:15 PM IST
    Metformin is a first-line treatment for type 2 diabetes and prediabetes. It is a cost-effective and popular and safe drug. Lately, Metformin has found...
    Study finds noninferior cardiovascular safety of linagliptin versus glimepiride in early diabetes

    Study finds noninferior cardiovascular safety of linagliptin versus glimepiride in early diabetes

    Deepanjana Sarkar25 Sept 2019 9:00 AM IST
    The dipeptidyl peptidase-4 inhibitor-linagliptin has demonstrated noninferiority in placebo-controlled cardiovascular safety trials however, its role...
    Elevated hs-CRP ups risk of diabetic nephropathy in diabetes patients: Diabetes Care

    Elevated hs-CRP ups risk of diabetic nephropathy in diabetes patients: Diabetes Care

    Medha Baranwal Baranwal24 Sept 2019 8:28 PM IST
    The role of low-grade systemic inflammation as evidenced by elevated high sensitivity C-reactive protein (hsCRP) levels in the pathogenesis of...
    Diabetics with raised blood sugar have higher risk of frailty later in life

    Diabetics with raised blood sugar have higher risk of frailty later in life

    Medha Baranwal Baranwal26 Sept 2019 8:55 AM IST
    Delhi: People with overt diabetes or raised HbA1c or fasting blood sugar levels have a higher risk of frailty throughout later life. Non-frail...
    Modify risk rather than merely relying on blood sugar lowering drugs in diabetes: DECLARE-TIMI

    Modify risk rather than merely relying on blood sugar lowering drugs in diabetes: DECLARE-TIMI

    Medha Baranwal Baranwal27 Sept 2019 7:28 PM IST
    Modify risk rather than merely relying on blood sugar lowering drugs in diabetes, finds DECLARE-TIMI Phase IIIB trial.Researchers, based on their...
    Among other benefits, Hormone therapy may decrease incidence of diabetes in women

    Among other benefits, Hormone therapy may decrease incidence of diabetes in women

    Hina Zahid27 Sept 2019 8:10 PM IST
    Hormone therapy is advocated in postmenopausal women to help balance estrogen and progesterone in women around the time of menopause. It can help...
    Patient develops pemphigoid lichen planus after use of diabetes drug: Case Report

    Patient develops pemphigoid lichen planus after use of diabetes drug: Case Report

    Medha Baranwal Baranwal30 Sept 2019 7:28 PM IST
    Spain: A recent case report published in the International Journal of Dermatology describes the case of an 80-year-old woman who developed blisters on...
    Diabetes remission possible with weight loss of 10% or more in first five years, finds study

    Diabetes remission possible with weight loss of 10% or more in first five years, finds study

    Dr. Kamal Kant Kohli Kohli30 Sept 2019 8:10 PM IST
    Type 2 diabetes remission is possible with 'achievable' weight loss, finds a new study.Researchers at the University of Cambridge have found that...
    PrevNext

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 12 Oct 2022 7:06 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok